Interleukin-1beta suppression in Blau syndrome: comment on the article by Martin et al.
Masumoto
Junya
J
Yamazaki
Takashi
T
Ohta
Kouichi
K
Nakayama
Jun
J
Agematsu
Kazunaga
K
D001168:Arthritis / Q000235:genetics* / Q000378:metabolism; D002478:Cells, Cultured; D003872:Dermatitis / Q000235:genetics* / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use; D053583:Interleukin-1beta / Q000096:biosynthesis / Q000235:genetics*; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000378:metabolism; D053473:Nod2 Signaling Adaptor Protein / Q000235:genetics / Q000378:metabolism; D017354:Point Mutation; D012873:Skin Diseases, Genetic / Q000235:genetics* / Q000378:metabolism
D053590:Interleukin 1 Receptor Antagonist Protein; D053583:Interleukin-1beta; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein